Exemestane is a useful second-line agent for hormone-sensitive advanced breast cancer New drugs and disease management 12 February 2013 Pages: 1 - 4
Minimising neurological damage takes priority in acute liver failure New drugs and disease management 12 February 2013 Pages: 4 - 7
Treatment of severe hypoxia relies on supportive therapy New drugs and disease management 12 February 2013 Pages: 7 - 10
Antibacterial-induced nephrotoxicity in the newborn can be avoided Drug reactions and interactions 12 February 2013 Pages: 10 - 12
QOL measurements: an important part of Parkinson’s disease assessment Drug economics and quality of life 12 February 2013 Pages: 13 - 16